Clinical Trials Directory

Trials / Completed

CompletedNCT00964808

Norspan Versus Oxycontin as Postoperative Painkiller to Proximal Extracapsular Fractures of the Femur

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
76 (actual)
Sponsor
Vejle Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Effective treatment of pain after hip fractures is very important but difficult. It is often an old patient who has many adverse effects with the use of morphine. This is a randomized pilot study where the investigators want to compare Norspan plaster to Oxycontin tablets to patients with particular kind of hip fractures. The investigators will evaluate mobilization, pain, use of rescue medicine, adverse effects and length of stay. No clinical study about the effect of Norspan as acute painkiller has never been done before. Can the investigators get the patients mobilized earlier with less adverse effects?

Conditions

Interventions

TypeNameDescription
DRUGBuprenorphineStart: Day 0 (T=0), 10 micrograms/t until the day of discharge from the Hospital. New plaster at T= 7 days.
DRUGOxycodoneStart: 10 hours (+/- 2 hours) after the operation. Dosage: 10 mg \* 2 pr. day until time to discharge from the Hospital or latest at day 12.

Timeline

Start date
2009-09-01
Primary completion
2013-05-01
Completion
2013-08-01
First posted
2009-08-25
Last updated
2014-12-08

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT00964808. Inclusion in this directory is not an endorsement.

Norspan Versus Oxycontin as Postoperative Painkiller to Proximal Extracapsular Fractures of the Femur (NCT00964808) · Clinical Trials Directory